Results 111 to 120 of about 1,954,791 (139)

Rituximab in the treatment of anti-HMGCR immune-mediated necrotizing myopathy: Two cases successfully treated. [PDF]

open access: yesRheumatol Immunol Res
Micheli G   +10 more
europepmc   +1 more source

Clinicopathological features of anti-HMGCR and anti-SRP myopathies that do not satisfy the EULAR/ACR criteria of inflammatory myopathies. [PDF]

open access: yesRheumatology (Oxford)
Komaki S   +27 more
europepmc   +1 more source

Pediatric case of immune-mediated necrotizing myopathy with anti-HMGCR antibodies and dermatomyositis skin rash. [PDF]

open access: yesPediatr Rheumatol Online J
Cavillon T   +6 more
europepmc   +1 more source

Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy. [PDF]

open access: yesAnn Rheum Dis
Tiniakou E   +13 more
europepmc   +1 more source

Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy. [PDF]

open access: yesNeurol Neuroimmunol Neuroinflamm
Llansó L   +22 more
europepmc   +1 more source

Anti-HMGCR Myopathy. [PDF]

open access: yesJ Neuromuscul Dis, 2018
Mohassel P, Mammen AL.
europepmc   +1 more source

Home - About - Disclaimer - Privacy